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Clinical–insurer engagement to improve
maternity safety in the UK, Ireland,
Sweden and Australia
Christopher W H Yau1,2 , Oliver Quick3 and
Timothy Draycott1
Abstract
Objective: To explore different models of clinical–insurer engagement around maternity safety and to understand how
state insurers could and should engage with clinical staff to improve outcomes and reduce harm.
Design: Semi-structured interviews and focus groups were conducted with senior representatives from state insurers.
Transcripts were analysed to identify different models of engagement. Themes were also elicited from the transcripts. A
further one-day focus group allowed for clarification and elaboration of these themes.
Participants: Senior representatives from state insurers in England, Scotland, Wales, Republic of Ireland, Sweden and
Victoria, Australia.
Results: A variety of clinical engagement activities were undertaken by the insurers. These included training on claims
and risk management, hospital site visits, facilitating multi-professional network meetings and working with clinical
experts to develop best practice recommendations. Some insurers engaged with frontline clinical staff through collab-
orative patient safety programmes. The themes (identity and size, data and research, incentivising improvement and
system integration) were important for considering the role of state insurers within health systems and how insurers
could engage with clinical teams.
Conclusions: This study identified different examples of clinical–insurer engagement. Whilst this was encouraging, the
relationships between insurers and clinical teams could be developed further. Insurers and clinical staff could still
collaborate more closely and work together in improving patient outcomes. Whilst not specifically their domain,
insurers do have a role in patient safety. Closer clinical collaboration may strengthen this contribution.
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Introduction
Across the world, birth is not as safe as it could and
should be. Preventable harm is not only a tragedy for
the families affected, but with rising treatment and
litigation costs, it is a significant drain of financial
resources from healthcare systems. In 2016–17, the
English National Health Service Litigation Authority
paid out £1.7 billion in compensation and fees for
clinical negligence claims. Alarmingly, the value of
the obstetric claims received in 2016/17 is expected
to reach £2 billion.1 These are claims that no one
wants to receive or pay. It is money lost to the health-
care service and patient care. However, these pay-
ments, and in particular the prevention of the
underlying incidents, may help to drive improvement
in health systems. Agencies that provide indemnity
insurance for clinical negligence are not patient
safety organisations but can have a role in preventing
harm and avoiding litigation.2,3 Whilst there is evi-
dence of involvement by both private and state insur-
ers in patient safety initiatives,4–7 there has been little
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empirical research to understand the strategies
employed by state insurers to engage with clinical
teams. A better understanding of the different ways
state insurers interact with clinicians could be useful in
informing future practice. In this study, we explored
different models of engagement by examining the
work of six state insurers in Europe and Australia.
We focused on maternity care given its disproportion-
ate litigation burden – in England, obstetric cases rep-
resent 10% of the number of claims but constitute
50% of the total value.1 Our aim was to describe
how different state insurers engage with clinical staff
to improve outcomes and prevent harm, and explore
how such engagement can be more effective.
Methods
We examined different models of insurer engagement
with clinical providers (clinical–insurer engagement) at
the following six state insurers:
• NHS Litigation Authority (NHSLA) – England
• Welsh Risk Pool Services (WRPS) – Wales
• Central Legal Office (CLO) – Scotland
• State Claims Agency (SCA) – Republic of Ireland
• Landstingens €Omsesidiga F€ors€akringsbolag (L€OF) –
Sweden
• Victorian Managed Insurance Authority (VMIA) –
Victoria, Australia
These insurers were chosen to compare current practice
in England, Wales, Scotland and the Republic of
Ireland. Sweden was included to enable comparison
with an administrative ‘no-fault’ compensation
scheme run by a national mutual insurance company
(L€OF). The VMIA was included as it has funded qual-
ity improvement initiatives for maternity units across
Victoria.6 The key features of each insurer and the con-
text in which they operate are summarised in Figure 1.
Many of the participants did not identify with the term
insurer as there are no formal insurance contracts
between their organisation and their clients.
Indemnifier or reimburser are thus more accurate
terms to describe some of these organisations.
However, for ease of reference, we refer to all agencies
that manage clinical negligence claims and provide
compensation as insurers. We defined engagement to
include any sort of partnership or relationship which
is specifically focussed on improving safety and
outcomes.
We carried out semi-structured interviews (with one
participant) or focus groups (with more than one par-
ticipant) with senior representatives from each insurer.
To maintain confidentiality, the names of the partici-
pants and their affiliations have not been provided.
However, the roles of the participants from all six
state insurers have been listed in Table 1. The inter-
views/focus groups took place between August 2016
and February 2017 and were conducted by OQ
(Reader in Law) and CY (Obstetric Registrar and
Research Fellow). The exception was for the VMIA,
where CY facilitated focus groups. A basic topic guide
(see Appendix 1) was utilised at each interview/focus
group. All interviews/focus groups were audio-
recorded when permission was given (all except one)
and were transcribed. Analysis was supported by a
one-day focus group with all participants who provided
feedback on our preliminary analysis of the data and
an opportunity for collective reflection on the emerging
themes.
We followed a Grounded Theory approach, defined
as the ‘discovery of theory from data systematically
obtained from social research’.8 This approach is well
suited to investigating areas such as this where there is
limited existing research. The transcripts and field notes
were analysed independently by both researchers before
observations were compared and themes identified.
There was a high degree of similarity in terms of our
observations and no disagreements within the research
team in identifying themes from the data. We employed
deviant case analysis (i.e. whenever a theme or catego-
risation was identified within the data, each interview
was re-examined for counter-examples and disconfirm-
ing data). This afforded greater confidence that the iden-
tification of themes was trustworthy and reduced bias.
Ethical approval was obtained from the University of
Bristol Faculty of Health Sciences Research Ethics
Committee. Participants were provided with informa-
tion leaflets regarding the study and written consent
was obtained prior to the interviews/focus groups.
Results
Insurers were involved in a wide variety of engage-
ment activities. We classified these into ‘general’, ‘clin-
ical’ and ‘research’ engagement. All insurers
participated in general engagement activities, for
example providing claims data to hospitals, conduct-
ing claims reviews, and hosting quality and safety
conferences. There were also a range of initiatives
and projects whereby insurers attempted to engage
with clinical staff and also support research activity.
All engagement activities discussed by the insurers are
summarised in Table 2.
There was no consensus amongst respondents on
the best way of ensuring effective clinical–insurer
engagement. Whilst there was no lack of activity,
there was an acknowledgement that engagement
with frontline clinicians (as opposed to managers) is
challenging and somewhat under developed. This was
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reflected in the following quotes from respondents at
the NHSLA:
"What do we need to do to be engaging with the clini-
cians on the ground? How can we best develop and
start to move things forward?"
"I think in an ideal world we would have really pulled
off much closer clinical engagement, and if I’m being
realistic, I’m not sure we’d do it at hospital level but
there’s the potential to do it at speciality level."
L€OF appeared to have been successful in engaging with
specialists by collaborating with their professional
organisations. It has provided financial and adminis-
trative support for safety improvement projects focus-
sing on perinatal care, prosthesis-related infections,
abdominal surgery, trauma care and the use of drugs
NHS Litigation Authority (NHSLA) - England  
• The English NHS covers a population of 54 million and operated a budget of 
£101.3 billion in 2015-16.  
• The NHSLA was established in 1995 in order to provide indemnity cover for 
legal claims against the NHS. 
• It was rebranded as NHS Resolution in April 2017.  
• The Clinical Negligence Scheme for Trusts (CNST) is a risk pooling scheme 
made up of 530 NHS Trust members which operates on a not-for-profit and 
pay-as-you-go basis, with no limits or excesses.  
• The scheme collects annual membership subscriptions from each Trust to 
cover the projected costs of the scheme in that year, and these are calculated 
based on three factors: 
I. A risk-based element (staffing size and activity levels). 
II. Claims experience over past 5 years. 
III. Known outstanding claims 
Welsh Risk Pool Services (WRPS) - Wales 
• Wales has a population of around 3 million and NHS Wales delivers healthcare 
through seven local Health Boards and three NHS Trusts.  
• Welsh Risk Pool Services (WRPS) was set up in the early 1990s 
• WRPS funding comes centrally from the Welsh Government, via the NHS 
Shared Services Partnership in Wales.  
• Hospitals are allocated resources in accordance with the population that they 
serve, a proportion of which gets diverted to the WRPS beforehand. 
State Claims Agency (SCA) - Republic of Ireland 
• In Ireland, the Health Service Executive (HSE) is responsible for providing 
public healthcare for a population of around 5 million.  
• Residents are entitled to hospital services free of charge, however, there are 
some fees designed to act as deterrents for the misuse of services.  
• The SCA manages all clinical negligence claims against the State.  
• It is funded by taxation so there is no risk pool.  
• The SCA has a multi-professional clinical risk team, made up of 14 members, 
to assist in the investigation and risk management of clinical negligence claims.  
Central Legal Office (CLO) - Scotland 
• The CLO was created in 1974 and forms part of National Services Scotland, a 
non-departmental public body which is part of the NHS.  
• It handles legal claims brought against the health service and all work is 
handled in house by a team of 30 solicitors.   
• The Clinical Negligence and Other Risks Indemnity Scheme (CNORIS), akin to 
the English CNST, is a risk and financial pooling scheme which was 
established in 1999.  
• Health Boards are mandated to join the scheme, which is managed by NHS 
National Services Scotland, and overseen by the Scottish Government, which 
is required to approve claims in excess of £250,0000.  
• The CLO focuses exclusively on providing legal advice and guidance to its 
members in relation to negligence claims.  
Figure 1. Key features and context of insurers.
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in primary care. They were able to cite numerous exam-
ples of effective engagement with clinicians:
"We work with midwives, infectious specialists, obste-
tricians, primary GPs. We reach them via their
professional organisations, and our role here is to
administer and support financially. Then hopefully we
get the perfect marriage here."
A strong feature of the approach of L€OF was its
emphasis on inspiring appropriate professional norms
around learning and improvement as opposed to being
overly prescriptive:
"We’re quite cautious about telling – it’s not that we
say, for instance, 'L€OF does not say that you should do
it this way.' We don’t say that. We say that we have
helped the professionals to find the best practice to do
it and we have supported them. . .So, what we actually
work with there are professional norms. 'We help the
professions to develop their professional norms. ‘It’s
okay to do it this way. It’s not okay to do it this
way.' "
It should be noted that Sweden operates an adminis-
trative scheme for compensating patients for avoidable
harm. This is different to the fault-based systems in the
UK, Republic of Ireland and Australia. In Sweden,
claims are assessed with reference to whether injuries
are ‘avoidable’ rather than being caused by negligence,
Figure 1. Continued.
Table 1. Summary of participant roles.
Roles of participants
Head of clinical risk
General manager of medical indemnity
Chief medical officer
Head of business development
Risk management assessor
Director
Head of litigation
Senior risk advisor
Head of clinical claims
Deputy chief executive officer
Actuarial analyst
Manager of health informatics
Director of safety and learning
Medical indemnity portfolio manager
Scheme manager
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and care is assessed by reference to the ‘experienced
professional standard’ rather than the standard of the
‘reasonable practitioner’ as it is in fault-based systems.
The Swedish Patient Injury Act, introduced in 1997,
establishes the right for patients to be compensated for
avoidable injury. This results in around a third of all
claims being compensated within eight months of the
injury being reported.9 Within this system, the insurer
is predisposed to offer compensation wherever possible:
"I think it’s also important to stress that we always try,
if it’s possible, to find a way to compensate. That’s how
we work. We are not here to save money. That’s impor-
tant to save money. We just want to make sure that if
we can pay compensation we should do that and try to
find a possibility. So, we don’t want to be this ugly
insurance company that just wants to fool everyone.
We really want to help people."
The Scottish Government has considered introducing
no-fault liability but has (so far) decided against doing
so.10 The UK Department of Health has recently con-
sulted on creating a ‘Rapid Resolution and Redress
Scheme’ for obstetric cases which is modelled on the
Swedish system.11 This scheme proposes to offer earlier
support and financial redress for children with birth-
related brain injuries in England. Ahead of this, the
NHSLA introduced an Early Notification Scheme in
April 2017 which requires Trusts to notify them of all
maternity incidents involving severe brain injury and
which allows families to be compensated without issu-
ing legal proceedings.12 Interestingly, the Welsh
Government has introduced a system of redress for
low-value cases (under £25,000). Under this ‘Putting
Things Right’ Scheme, concerns regarding clinical serv-
ices provided by NHS Wales are reported to the hos-
pital. If there is a suggestion of medical harm, the
hospital has to carry out an investigation to determine
whether there is qualifying liability under the well-
known Bolam test for assessing negligence.13 If quali-
fying liability is demonstrated, the hospital has a
responsibility to consider the value of financial com-
pensation. If the value is less than £25,000, then the
hospital can offer compensation directly to the patient
as part of this Scheme. The Welsh government can then
reimburse this fee. Patients waive their right to file a
legal claim by accepting this redress package.
Even within the fault-based system in the UK, there
were important differences in terms of the mechanics of
paying for claims. In England, Hospital Trusts pay a
premium to be members of an indemnity scheme (the
Clinical Negligence Scheme for Trusts) which is admin-
istered by the NHSLA. This means that the NHSLA
takes responsibility for managing claims and paying
out compensation. Whereas in Wales, if a settlement
is agreed, the hospital pays the settlement first, before
applying to the WRPS for reimbursement. Hospitals
are only reimbursed if an adequate learning plan has
been implemented and WRPS has the power to delay
or even refuse reimbursement at its discretion.
"It is a sanction that is used so they know it is used" (on
discussing the possibility that hospitals may not be
reimbursed after paying a claim).
In the Republic of Ireland, the reporting of any
adverse healthcare incidents to the SCA is a statutory
requirement. Whilst there is no formal penalty for non-
compliance, if a claim is not preceded by an incident
report, the SCA can decline to cover the cost of the
claim and the hospital would have to pay out
themselves.
Engagement appeared to be easier in smaller health
systems. Respondents from Wales made repeated
Table 2. Summary of engagement activities.
General Clinical Research
Providing leaflets on services Operating incentive schemes Learning from claims data
Claims reviews/audits Performing themed reviews Co-applicants for research grants
Hosting national safety campaigns Facilitating national maternity network Claims database available for
research purposes
Obtaining feedback from members Training for clinical staff Supporting early research
Signposting to good practice Performing site visits ‘In-house’ health informatics team
Liaising with other organisations Providing financial and/
or administrative support for
patient safety initiatives
Research components to safety initiatives
Organising networks for claims managers Developing educational programmes Seeking formal research partnerships
Presentations at executive level Facilitating expert discussions
Hosting conferences
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reference to the relatively small size of their health sys-
tems and their ability to get to know key clinical
personnel.
"I think because Wales is smaller we’ve been able to
have a better handle on the risk management and the
training and the lessons that come out of the claims."
"From the point of view of claims management, it’s
easier in a smaller place where you have only about
10% number of the claims and just geographically, it
seems easier to manage."
All insurers possess a significant amount of claims
data. However, there was recognition that merely pos-
sessing the data does not ensure improvement:
"Data is only going to start to signpost you to look at
which stone you might want to turn over. It’s not going
to tell you how to fix those problems necessarily."
"So, we can capture more and more data if we want, we
can capture more and more granular data but is it
going to necessarily take us that further forward in
terms of actually supporting and engaging with people
on the ground to improve? It might give them more
tools but more information about what they already
know is an issue isn’t helping them solve that issue
whereas the provision of potential support [or] interven-
tion. . .to help them get past that would be, I think, a
really positive step towards that improvement."
Some have been using their claim analyses to direct
improvement efforts towards problematic areas.
"We want our patient safety activities to be data-
driven. Targeted work, we can’t work with everything,
so we have to be selective."
Finally, many of the insurers seemed to take a pro-
active approach to risk management and the recent
rebranding of the NHSLA to NHS Resolution,12
with its focus on learning and prevention, is evidence
of this.
"Yeah, we’re insurers and we’re there to make sure that
the clients are well looked after when things go wrong
but, at the same time, we see our role to prevent that
harm happening in the first place."
"So, all of the players, whether you’re the national lead
for maternity for NHS England or you’re in improve-
ment or you’re here, we’ve all got the same aim. . .what-
ever we can possibly do in a combined way to reduce
harm."
"A dollar’s a dollar at the end of the day but if we’re
preventing harm/saving lives it’s a whole different story
and I think it generates more enthusiasm for all of us
knowing that we’re looking for something that’s going
to help."
Discussion
This study demonstrated that state insurers participat-
ed in a wide range of general, clinical and research
engagement activities. There were many models of clin-
ical–insurer engagement but there was a strong sense
that this relationship could be improved further. Our
analysis of the responses allowed us to identify the fol-
lowing themes which appear to be centrally important
for effective clinical–insurer engagement: insurer iden-
tity and size, their use of data and commitment to
research and how they attempt to incentivise improve-
ment and integrate the system.
Insurer identity and size
A fundamental question surrounds the identity of each
insurer and what they regard as their main priorities.
Whilst all the insurers are responsible for protecting the
interests of their members, both financial and reputa-
tional, they must also compensate patients for negligent
or avoidable harm. This raises the significant challenge
of how insurers can satisfy all of these different stake-
holders whilst maintaining their trust and confidence.
Balancing the interests of patients (particularly those
who bring claims) whilst defending the financial inter-
ests of the health system is particularly challenging.
Apart from L€OF, which operates within a system
which provides an entitlement to compensation for
avoidable harm, the other insurers have operated
within systems which have (historically) been focused
on denying or defending claims. It is important not to
overlook the impact of these different systems on how
insurers identify themselves and what they consider to
be their main priority. For example, L€OF functions as
an insurance company which essentially regards
patients as its customers and attempts to resolve
claims to their satisfaction. This contrasts with the
approach of insurers in fault-based systems which
have tended to focus on satisfying its clinical provider
members. We would tentatively suggest that no-fault
systems, with an emphasis on efficient resolution of
claims and a less adversarial approach, are more con-
ducive to effective clinical–insurer engagement.
Effective engagement also appeared to be easier in
smaller health systems. It was a foreground assumption
of this research that engagement might be easier in
smaller health systems, and the responses appear to
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confirm this. One of the explanations for the positive
examples of engagement in Sweden and Victoria is the
relatively small size of their health systems. This
presents challenges for such engagement in bigger
health systems such as the English NHS and raises
the possibility of larger insurers operating at regional
level in order to help facilitate more effective
engagement.
Data and research
Claims data can complement clinical data and improve
the potential learning from harmful events. However,
data collected for claims purposes are limited in a
number of ways. First, it presents a skewed picture in
only focusing on failure rather than success. Second,
given the time lag between the incident date and the
claim date, it may not accurately reflect the safety of
current care being delivered. Third, such data are col-
lected for narrower legal rather than much broader
clinical purposes. Combining clinical and claims data
would be challenging given the need to integrate many
different databases. Insurers and clinicians should
work in partnership to carefully design an accessible
system that will facilitate, rather than impede, the anal-
ysis of claims and clinical data together. This would
result in more data being converted into meaningful
information. Furthermore, a consensus on the taxono-
my to be used between insurers and clinicians world-
wide would encourage data sharing and the formation
of larger datasets. This would increase opportunities
for learning and foster a greater sense of collaboration.
In addition to developing a better way of using data,
insurers could work more closely with clinical experts
and draw on academic expertise in designing patient
safety research. In particular, insurers could fund col-
laborative research projects as part of their risk miti-
gation initiatives.6,7 The VMIA has supported the
implementation of a multi-professional obstetric emer-
gencies training programme (PROMPT) throughout
Victoria. Each participating unit received funding
from the VMIA to help with training costs. An initial
analysis found that the programme was associated with
improvements in staff attitudes towards safety, team-
work and perception of management. There were also
significant improvements in some clinical outcomes
during or after training.6 The VMIA is currently col-
laborating with a UK charity (PROMPT Maternity
Foundation) to evaluate the state-wide impact of this
training package.
Incentivising improvement
Incentives can play an important role in encouraging
improvement but there is no agreement on the perfect
model for this. Though not formal regulators, insurers
can exert some regulatory influence by setting targets
(such as adopting evidence-based patient safety pro-
grammes) linked with monetary and administrative
incentives.14 Other financial incentives could be in the
form of premium discounts or returns subject to certain
assessment criteria. The NHSLA previously offered
discounts of up to 30% on hospitals’ premiums if
their standards were met. These were process measures
covering governance, learning, workforce, environ-
ment, training and procedures.15 These discounts and
standards were eventually stopped as there was no clear
correlation between compliance with standards and
better outcomes.16,17 Eligibility for discounts on premi-
ums, therefore, should include assessment of both pro-
cesses and clinical outcomes.
There is a considerable time lag in maternity claims
between the incident and settlement, usually due to the
time needed for a diagnosis and long-term prognosis to
be made. As a result, premiums charged to maternity
units may still be influenced by previous events, even if
care has significantly changed since they occurred.
There is an argument that premiums are too backward
looking and do not reward current, good practice.
Future pricing strategies should take this into
consideration.
Non-financial incentives can also be very powerful
and could include releasing data for regional/national
benchmarking or promoting professionalism. Such
incentives could be considered universal and not reliant
on pricing strategies or premiums. Negatively focused
incentives such as imposing penalties on substandard
care may also be utilised. These measures, however,
may perpetuate poor care by punishing those that
need help in improving.
Further exploration of different incentive models,
including their evaluation and implications for policy,
is clearly required. Insurers have the financial resources
and administrative capacity to help develop and run
incentive schemes. Crucially, from these interviews
and focus groups at least, there appeared to be a grow-
ing appetite for new and better incentive plans, as dem-
onstrated by proposals in England to introduce a new
discount scheme in 2018/19.18 Insurers, hospital staff
(both clinical and managerial) and other key agencies
in the health system should all be involved in the co-
design of future incentive models. This would ensure
system-wide coherence of objectives, which are realistic
and relevant to frontline services.
System integration
Many people and agencies in a health system contrib-
ute towards patient safety. However, an overcrowded
system may hinder rather than enhance quality
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improvement efforts. Poor communication and inade-
quate sharing of information between clinical teams or
organisations may lead to time wasted on reinventing
solutions that already exist elsewhere.19 The existence
of too many local processes creates more variability
within a health system, which may perversely under-
mine patient safety.19 The regulatory sector is similarly
congested. Many regulators have overlapping roles and
often duplicate data requests unnecessarily. This
bureaucratic burden wastes time and resources for
both the regulators and those being regulated.20
A more co-ordinated approach would help to align
the aims throughout a health system. Patient safety and
quality of care are more likely to improve if all the
drivers in the system – for example, policy, training,
incentivisation and regulation – are pointing to the
same objectives.21 An insurer is only one stakeholder,
amongst many others, in the pursuit for safer patient
care. Despite this, insurers may be ideally placed to
facilitate system integration through their multi-level
contacts and financial power. Insurers could work
together and liaise with organisations at all levels of
the health system.
This research is subject to some limitations. The
study design was limited to understanding engagement
from the perspective of key personnel at insurers. No
account was taken here of the perspectives of clinicians
or managers. Another limitation is the small sample
size of state insurers we selected to participate in this
study. As the insurers were purposefully chosen, there
will be an element of selection bias and our findings
may not be as representative as they could be. Data
saturation was also unlikely to have been achieved
through interviewing six state insurers, though our
sample size was limited by the time and resources
assigned for this work. Despite the limitations, there
has been little, if any, research in this area previously
so this work offers preliminary insights into how some
state insurers currently engage with clinical teams,
which other insurers may find helpful.
Conclusion
To conclude, this study identified different models of
clinical–insurer engagement, which include training
clinical staff on claims and risk management, hospital
site visits, facilitating multi-professional network meet-
ings and working with clinical experts to develop best
practice recommendations. Some insurers, notably the
VMIA and L€OF, have mainly engaged with frontline
clinical teams through collaborative patient safety ini-
tiatives. These projects were supervised by clinical
experts from the start and some appear to have had
beneficial effects on outcomes6 or litigation.7 Whilst it
was encouraging that many examples of clinical–
insurer engagement were elicited, there is scope for
this dynamic to be developed further.
Analysing the way that different insurers currently
work has allowed us to develop recommendations for
how state insurers could play a more effective role
within the healthcare system and how they may use
different levers to affect patient care and safety.
These recommendations fall within the categories
listed below. Insurers could:
• Improve integration of the health system:
 By using their system-wide contacts and influence
to coordinate and prioritise health-related
initiatives
 By signposting members to possible solutions or
directing them to relevant contacts
• Collaborate more closely with clinical experts and
other academics in the following:
 To create ways to combine clinical and claims data
 Implement safety initiatives with proven clinical
effectiveness
Undertake translational research together, with the
aim of applying this to multiple settings
• Use their resources to help improve patient care:
 By providing administrative support in collabora-
tive projects
By identifying problematic areas to focus on
through claims analyses
 By supporting collaborative research
• Utilise incentives to encourage improvement:
 By providing monetary support/incentives for
safety initiatives with proven clinical
effectiveness
 By providing premium discounts (where applica-
ble) when certain assessment criteria are met
 By adjusting their premium models (where appli-
cable) to influence current practice
 By supporting regional/national benchmarking
 By reaffirming professional pride and
professionalism
• Share learning and good practice with other insurers
Whilst this study primarily focussed on maternity
care, these recommendations may also be relevant in
other medical specialties. Insurers and clinical teams
could and should collaborate more closely to achieve
their common goals: improving patient outcomes and
reducing costly payouts.
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Appendix 1. Topic guide
Background
What is your job title? What does that entail?
Could you explain a bit about your organisation?
How is it funded?
Yau et al. 87
Management
Could you talk about the claims management process?
What happens when a claim is received?
Communication
How do communication channels open up with differ-
ent professional groups? Who initiates contact?
What is your approach to communicating with differ-
ent professional groups?
Prompt if needed:
• clinicians in general
• maternity teams
• researchers
• other personnel
Engagement and incentives (maternity)
How does your organisation engage with maternity
teams?
Do you offer any incentives and could you give some
examples?
What has worked well?
What has worked less well?
are there any administrative/organisational/legal bar-
riers to engaging with maternity teams?
Ideal standard
What do you think would be the ideal way of engaging
and collaborating with healthcare organisations/teams?
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